TABLE 2.
Odds ratios (95% Cl) for relationships between baseline characteristics of co‐morbid history/demographic variables and atrial fibrillation status group as an outcome
Baseline characteristic | Odds ratio (95% Cl) | Significance level |
---|---|---|
Age groups | ||
>75 years vs <45 years | 19.37 (17.88‐20.98) | <.0001 |
65‐74 years vs <45 years | 10.28 (9.50‐11.12) | <.0001 |
55‐64 years vs <45 years | 4.69 (4.32‐5.07) | 0.301 |
45‐54 years vs <45 years | 2.68 (2.47‐2.90) | <.0001 |
Gender (1 vs 0) | 0.65 (0.63‐0.67) | <.0001 |
Co‐morbid history | ||
Heart failure (1 vs 0) | 1.75 (1.65‐1.87) | <.0001 |
Hypertension (1 vs 0) | 1.64 (1.57‐1.72) | <.0001 |
Diabetes mellitus (1 vs 0) | 1.16 (1.11‐1.22) | <.0001 |
Ischemic stroke (1 vs 0) | 1. 21 (1.11‐1.33) | <.0001 |
Transient ischemic attack (1 vs 0) | 1.087 (0.97‐1.18) | .1821 |
Thrombo‐embolic events (1 vs 0) | 1.08 (0.88‐1.34) | .4632 |
Myocardial infarction (1 vs 0) | 1.04 (0.96‐1.13) | .3601 |
Peripheral artery disease (1 vs 0) | 1.12 (1.05‐1.18) | <.0001 |
Valvular disease (1 vs 0) | 1.48 (1.41‐1.56) | <.0001 |
Coronary artery disease (1 vs 0) | 1.42 (1.35‐1.49) | <.0001 |
Chronic sleep apnea (1 vs 0) | 1.22 (1.10‐1.35) | .0002 |
Chronic kidney disease (1 vs 0) | 1.17 (1.11‐1.24) | <.0001 |
Chronic obstructive pulmonary disease/bronchiectasis (1 vs 0) | 1.28 (1.22‐1.34) | <.0001 |
Major bleeding (1 vs 0) | 1.06 (1.00‐1.13) | .072 |
Cognitive impairment (1 vs 0) | 1.02 (0.93‐1.12) | .7185 |
Liver disease (1 vs 0) | 1.09 (1.02‐1.15) | .0071 |
Anemia (1 vs 0) | 1.09 (1.04‐1.14) | .0004 |
Lipid disorders (1 vs 0) | 0.89 (0.86‐0.93) | <.0001 |
Depression (1 vs 0) | 1.09 (1.03‐1.15) | .0029 |
Spondylosis and intervertebral discs (1 vs 0) | 1.07 (1.03‐1.11) | .0005 |
Osteoarthritis (1 vs 0) | 1.16 (1.12‐1.21) | <.0001 |
C‐index | 0.838 |
1‐Presence of condition or female for gender.
0‐Absence of condition or male for gender.
Results for main effect model.